Patents Assigned to Biomeasure, Incorporated
-
Publication number: 20090149378Abstract: The present invention is directed to peptide analogues of glucagon-like peptide-1, the pharmaceutically-acceptable salts thereof, to methods of using such analogues to treat mammals and to pharmaceutical compositions useful therefor comprising said analogues.Type: ApplicationFiled: May 6, 2008Publication date: June 11, 2009Applicants: Biomeasure, Incorporated, The Administrators of the Tulane Educational FundInventors: Zheng Xin Dong, David H. Coy
-
Publication number: 20060217300Abstract: The present invention is directed to peptide analogues of glucagon-like peptide-1, the pharmaceutically-acceptable salts thereof, to methods of using such analogues to treat mammals, and to pharmaceutical compositions useful therefor comprising said analogues.Type: ApplicationFiled: February 17, 2004Publication date: September 28, 2006Applicant: BIOMEASURE, INCORPORATEDInventor: Zheng Dong
-
Publication number: 20030119864Abstract: A family of compounds capable of inhibiting the activity of farnesyl transferase.Type: ApplicationFiled: October 18, 2002Publication date: June 26, 2003Applicant: Biomeasure Incorporated, a Massachusetts corporationInventors: Thomas D. Gordon, Barry A. Morgan
-
Patent number: 6307017Abstract: A linear (i.e., non-cyclic) analog of biologically active amphibian bombesin, mammalian gastrin-releasing peptide (GRP), or mammalian growth hormone releasing factor (GRF), having an active site and a binding site responsible for the binding of the peptide to a receptor on a target cell. Cleavage of a peptide bond in the active site of naturally occurring bombesin, GRP, or GRF is unnecessary for in vivo biological activity. The analog has one of the following modifications: (a) a deletion of an amino acid residue within the active site and a modification of an amino acid residue outside of the active site, (b) a replacement of two amino acid residues within the active site with a synthetic amino acid, a &bgr;-amino acid, or a &ggr;-amino acid residue, or (c) a non-peptide bond instead of a peptide bond between an amino acid residue of the active site and an adjacent amino acid residue.Type: GrantFiled: March 2, 1999Date of Patent: October 23, 2001Assignees: Biomeasure, Incorporated, The Administrators of the Tulane Educational FundInventors: David H. Coy, Jacques-Pierre Moreau, Sun Hyuk Kim
-
Publication number: 20010011072Abstract: The present invention relates to a method of inhibiting fibrosis in a patient. The method comprises administering a therapeutically effective amount of a somatostatin, a somatostatin agonist or a pharmaceutically acceptable salt thereof to said patent.Type: ApplicationFiled: January 16, 2001Publication date: August 2, 2001Applicant: Biomeasure, IncorporatedInventors: Michael D. Culler, Philip G. Kasprzyk
-
Patent number: 6268342Abstract: The present invention relates to a method of inhibiting fibrosis in a patient. The method comprises administering a therapeutically effective amount of a somatostatin, a somatostatin agonist or apharmaceutically acceptable salt thereof to said patient.Type: GrantFiled: May 10, 1999Date of Patent: July 31, 2001Assignee: Biomeasure IncorporatedInventors: Michael D. Culler, Philip G. Kasprzyk
-
Patent number: 6262229Abstract: The invention features somatostatin antagonists having a D-amino acid at the second residue.Type: GrantFiled: May 13, 1997Date of Patent: July 17, 2001Assignees: Biomeasure Incorporated, The Administration of the Tulane Educational FundInventors: David H. Coy, Barry Morgan, William Murphy
-
Publication number: 20010000344Abstract: A family of compounds capable of inhibiting the activity of prenyl transferases.Type: ApplicationFiled: December 1, 2000Publication date: April 19, 2001Applicant: Biomeasure IncorporatedInventor: Sun H. Kim
-
Patent number: 6180619Abstract: A family of compounds capable of inhibiting the activity of prenyl transferases. The compounds are covered by the four following formulas Each of the R groups is defined in the disclosure.Type: GrantFiled: June 16, 1998Date of Patent: January 30, 2001Assignee: Biomeasure, IncorporatedInventor: Sun H. Kim
-
Patent number: 6004928Abstract: The present invention relates to a method of decreasing body weight in a patient. The method includes the step of administering a therapeutically effective amount of a type-5 selective somatostatin agonist to the patient.Type: GrantFiled: May 13, 1998Date of Patent: December 21, 1999Assignee: Biomeasure, IncorporatedInventors: Michael Anthony Cawthorne, Yong-Ling Liu, Matthew V. Sennitt
-
Patent number: 5968903Abstract: The present invention is directed to a method of using somatostatin or a somatostatin agonist to inhibit the proliferation of Helicobacter pylori (H. pylori), which comprises administering to a patient in need thereof an effective amount of said somatostatin or somatostatin agonist. Preferably, a somatostatin sub-type receptor 2 (SSTR-2) selective somatostatin agonist is administered in a method of this invention. The inhibition of H. pylori proliferation is useful in treating various gastroduodenal diseases such as peptic ulcers, gastric cancer and gastric lymphoma.Type: GrantFiled: May 7, 1998Date of Patent: October 19, 1999Assignee: Biomeasure, IncorporatedInventors: Hiroshi Kaneko, Terunori Mitsuma, Koichi Yamashita, Barry Morgan
-
Patent number: 5821221Abstract: A copolymer comprising an N-acylated derivative, and a composition comprising said copolymer and a polypeptide, said polypeptide comprising at least one effective ionogenic amine, wherein at least 50 percent, by weight, of said polypeptide present in said composition is ionically bound to said polymer.Type: GrantFiled: September 9, 1997Date of Patent: October 13, 1998Assignee: Biomeasure, IncorporatedInventors: Shalaby W. Shalaby, Steven A. Jackson, Francis Ignatious, Jacques-Pierre Moreau
-
Patent number: 5773455Abstract: A family of compounds capable of inhibiting the activity of prenyl transferases. The compounds are covered by one of the two following formulas: ##STR1## Each of the R groups is defined in the disclosure.Type: GrantFiled: June 28, 1996Date of Patent: June 30, 1998Assignee: Biomeasure, IncorporatedInventors: Zheng Xin Dong, Sun H. Kim
-
Patent number: 5767274Abstract: A family of compounds capable of inhibiting the activity of prenyl transferases. The compounds are covered by either of the two following formulas ##STR1## Each of the R groups is defined in the disclosure.Type: GrantFiled: June 28, 1996Date of Patent: June 16, 1998Assignee: Biomeasure, IncorporatedInventor: Sun H. Kim
-
Patent number: 5763200Abstract: A method of determining the ability of a compound to both bind to somatostatin type-5 receptor ("SSTR-5") and inhibit amylin release. The method includes obtaining a preparation, either a cell preparation or a membrane preparation, which contains SSTR-5; incubating the preparation, the compound, and a SSTR-5 ligand, at least one of the ligand and the compound being detectably labeled; determining the ability of the compound to compete against the ligand for binding to SSTR-5; if and only if the compound is determined to be able to bind to SSTR-5, obtaining pancreatic cells; incubating the compound, the pancreatic cells, and an amylin release stimulator under conditions in which the amylin release stimulator would induce release of amylin from the pancreatic cells; and determining the ability of the compound to inhibit amylin release. Also disclosed is a method of treating hyper-amylinemia with a ligand selective for SSTR-5.Type: GrantFiled: May 12, 1995Date of Patent: June 9, 1998Assignee: Biomeasure, IncorporatedInventors: Simon Jon Dunmore, Michelle Davenport, Michael Anthony Cawthorne
-
Patent number: 5723578Abstract: Linear peptide analogs of bombesin with modified amino acid residues at various positions. A peptide of a group of bombesin analogs according to this invention contains either a --CH.sub.2 NH.sub.2 -- pseudopeptide bond, a (3S,4S)-4-amino-3-hydroxy- 6-methylheptanoic acid residue, or a (3S,4S)-4-amino-3- hydroxy-5-phenylpentanoic acid residue.Type: GrantFiled: June 7, 1995Date of Patent: March 3, 1998Assignees: The Administrators of Tulane Educational Fund, Biomeasure IncorporatedInventors: David H. Coy, Jacques-Pierre Moreau, Sun Hyuk Kim
-
Patent number: 5708135Abstract: A cyclic peptide analog of somatostatin wherein a disulfide bond links the N-terminus residue and the C-terminus residue.Type: GrantFiled: December 26, 1995Date of Patent: January 13, 1998Assignees: Biomeasure Incorporated, The Administrators of the Tulane Educational FundInventors: David H. Coy, John E. Taylor
-
Patent number: 5686418Abstract: A method of prolonging the survival of pancreatic cells transplanted in a patient. The method includes the step of administering a therapeutically effective amount of a somatostatin or a somatostatin agonist to the patient.Type: GrantFiled: April 8, 1996Date of Patent: November 11, 1997Assignee: Biomeasure IncorporatedInventor: Michael D. Culler
-
Patent number: 5665702Abstract: A copolymer comprising an N-acylated derivative, and a composition comprising said copolymer and a polypeptide, said polypeptide comprising at least one effective ionogenic amine, wherein at least 50 percent, by weight, of said polypeptide present in said composition is ionically bound to said polymer.Type: GrantFiled: June 6, 1995Date of Patent: September 9, 1997Assignee: Biomeasure IncorporatedInventors: Shalaby W. Shalaby, Steven A. Jackson, Francis Ignatious, Jacques-Pierre Moreau
-
Patent number: 5595973Abstract: A method of promoting regeneration of hemopoietic cells in a subject undergoing chemotherapy or radiotherapy, which method includes the steps of (i) administering to the subject a first amount of a hemopoiesis inhibitory factor, the first amount being effective to reduce the proliferation of hemopoietic cells during the chemotherapy or radiotherapy; and (ii) after the chemotherapy or radiotherapy, administering to the subject a second amount of a hemopoiesis growth factor, the second amount being effective to stimulate the proliferation of hemopoietic cells.Type: GrantFiled: September 12, 1994Date of Patent: January 21, 1997Assignee: Biomeasure IncorporatedInventor: Arthur E. Bogden